Overview

Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the prophylactic effects of Ranolazine on new onset atrial fibrillation in post-operative coronary artery bypass graft and valve surgery patient population at Staten Island University hospital.
Phase:
N/A
Details
Lead Sponsor:
Northwell Health
Collaborator:
Gilead Sciences
Treatments:
Ranolazine